SCHEMBL23314206

SCHEMBL23314206

C[C@@H]1[C@H](F)[C@H](C)O[C@@H]1CO[PH](=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15368857 0.75 FBP1 (0.40) —
SCHEMBL21184288 0.75 FBP1 (0.40) —
SCHEMBL21184290 0.75 FBP1 (0.40) —
SCHEMBL23797577 0.72 — —
SCHEMBL21184378 0.70 FBP1 (0.33) —
SCHEMBL21184380 0.70 FBP1 (0.33) —
SCHEMBL19940051 0.69 — —
SCHEMBL24500006 0.69 CA2 (0.38) —
SCHEMBL12899516 0.69 — —
SCHEMBL13941424 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10995335-B2 RNAi agents and compositions for inhibiting expression of angiopoietin-like 3 (ANGPTL3), and methods of use Arrowhead Pharmaceuticals, Inc. (US) 2021-05-04 — — US disclosed
Send feedback